Table 2.
Physician Risk Assessment and Guideline Concordance
| Physician-Assessed Pretest Probability | All n = 25 (%) | Cancer n = 3 (%) | Benign n = 22 (%) |
|---|---|---|---|
| Pretest probability ≤ 5% | |||
| Guideline concordant CT surveillance | 12 (48.0) | 0 (0.0) | 12 (54.5) |
| More aggressive | 13 (52.0) | 3 (100.0) | 10 (45.5) |
| PET | 9 (36.0) | 2 (66.7) | 7 (31.8) |
| PET ≤ 30 d before surgery | 1 (4.0) | 1 (33.3) | 0 (0.0) |
| Biopsy | 3 (12.0) | 0 (0.0) | 3 (13.6) |
| All n = 138 (%) | Cancer n = 114 (%) | Benign n = 24 (%) | |
|---|---|---|---|
| Pretest probability ≥ 60% | |||
| Guideline-concordant surgerya | 35 (25.4) | 33 (28.9) | 2 (8.3) |
| More conservative | 103 (74.6) | 81 (71.1) | 22 (91.7) |
| CT | 10 (7.2) | 5 (4.4) | 5 (20.8) |
| PETa | 78 (56.5) | 63 (55.3) | 15 (62.5) |
| Biopsy | 15 (10.9) | 13 (11.4) | 2 (8.3) |
a
PET performed within 30 d of surgery was considered a staging PET scan and concordant with guidelines.